NinePoint Medical said today that it inked a long-term deal with Merit Medical (NSDQ:MMSI) division Endotek to distribute its NvisionVLE optical coherence tomography device that includes strategic investment of an unspecified amount.
“NinePoint Medical is committed to providing GI physicians an elegant and cost-effective OCT imaging solution to enable early and accurate diagnosis,” president & CEO Christopher von Jako said in prepared remarks. “Merit Medical Endotek is the ideal partner as they have the reputation, clinical experience, and complementary product portfolio to grow this business.”
“We are very excited to form this partnership in order to provide NinePoint Medical’s highly innovative OCT imaging system to our customers and other clinicians around the world,” added Merit founder, chairman & CEO Fred Lampropoulos. “Endotek is a market leader in GI solutions, and we share NinePoint Medical’s vision of improving early cancer detection and thereby improving patient outcomes while reducing healthcare costs.”